Investing RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 by admin June 4, 2025 June 4, 2025 Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 Download the PDF here. This post appeared first on investingnews.com previous post 5 Biggest Blockchain ETFs in 2025 next post Adam Rozencwajg: Gold Stock Gains, Silver and Uranium Prices — Plus PGMs Bull Case You may also like Investor Webinar, Wednesday 5th Nov, 11:30am AEDT November 3, 2025 Valeura Energy Inc. Announces Manora Drilling Exceeds Management’s... March 9, 2026 Providence Gold Mines Inc. La Dama de Oro... January 10, 2026 Is it Time to Take Profits? Experts Share... January 31, 2026 Acquisition of “Thompson Falls” High-Grade Antimony Project Adjacent... February 5, 2026 Acquisition Legal DD Complete July 2, 2025 Quimbaya Gold Closes $4 Million Financing and Expands... July 5, 2025 Graphite Market Forecast: Top Trends for Graphite in... January 20, 2026 Rapid Critical Metals: Visit us at PDAC 2026... February 20, 2026 Silver Stocks: 5 Biggest Companies in 2025 September 3, 2025